All potential predictors of symptomatic change and adherence were measured at baseline except for treatment program factors, which were measured during treatment (e.g. treatment credibility was assessed during the second week) or after treatment (e.g. adherence).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}